Veranex, a concept-to-commercialization service provider, completed the acquisition of IMMR, a preclinical science organization. Financial terms were not disclosed. “We are excited to welcome the world-class and market leader IMMR to Veranex. Veranex is focused on the needs of the MedTech industry and this acquisition enhances our long-term ability to meet the end-to-end needs of MedTech companies in one organization. Veranex’s clients will benefit from IMMR’s 30-plus years of experience in the design and conduct of preclinical studies, expertise in complex cardiovascular and non-cardiovascular procedures, and state-of-the-art surgical suites and husbandry facilities, all unparalleled for leading successful completion of sophisticated studies with novel interventional or surgical technologies," Patrick Donnelly, Veranex Executive Chairman.